Fundraising Fox

Samantha Truex

Investor

Board Member at Avalo Therapeutics · Chief Executive Officer at Oblenio Bio

Cambridge, Massachusetts

Writes $10M – $50M checks · typically $25M

About

CEO of Oblenio Bio and CEO-in-Residence at Aditum Bio. Previously founding CEO of Upstream Bio, CEO of Quench Bio, COO of Synlogic, and CBO for Padlock Therapeutics. Held VP of Corporate Development role at Biogen leading transactions and serving as program executive for marketed products. Also has corporate development experience at Genzyme and Chiron Diagnostics.

Chief Executive Officer at Oblenio Bio

Intro paths

In turn, Samantha can intro founders to Oblenio Bio's investors below.

Experience

  1. Oblenio BioCEO of Oblenio Biocurrent2025 — presentCambridge, MA
  2. Avalo TherapeuticsBoard Member, Chair of Nom & Gov Committee, Member Audit Committeecurrent2024 — present
  3. ArtiosChair of the Board of Directorscurrent2022 — present
  4. Upstream BioChief Executive Officer2021 — 2024Waltham, Massachusetts, United States
  5. HotSpot Therapeutics, Inc.Member of the Board; Chair of Audit Committee2018 — 2022Cambridge, MA
  6. Quench BioCEO2018 — 2021Cambridge, MA
  7. Synlogic TherapeuticsCOO and Head of Corporate Development2016 — 2017Cambridge, MA
  8. Padlock Therapeutics, Inc.Chief Business Officer2014 — 2016Cambridge, MA
  9. BiogenVP Corporate Development2013 — 2014Cambridge, MA
  10. BiogenVP, Program Executive for Fampyra2012 — 2013Cambridge, MA
  11. BiogenVice President, Business Development2010 — 2012
  12. BiogenSr. Director, Head of Product and Commercial Development for Hemophilia2008 — 2010
  13. BiogenSr. Director, Corporate Development2006 — 2008
  14. GenzymeDirector, Business Development1998 — 2006
  15. Chiron CorporationAssociate, Business Development1997 — 1998
  16. Health AdvancesAssociate Consultant1995 — 1997

Skills & more

Mergers & Acquisitions14Corporate Development12Business Development12Biotechnology26Commercialization9Biopharmaceuticals23Drug Development7Cross-functional Team Leadership6

From Samantha's professional profile.

Colleagues at Avalo Therapeutics

Frequently asked questions

Who is Samantha Truex?
CEO of Oblenio Bio and CEO-in-Residence at Aditum Bio. Previously founding CEO of Upstream Bio, CEO of Quench Bio, COO of Synlogic, and CBO for Padlock Therapeutics. Held VP of Corporate Development role at Biogen leading transactions and serving as program executive for marketed products. Also has corporate development experience at Genzyme and Chiron Diagnostics.
Where does Samantha Truex work?
Samantha Truex is Board Member at Avalo Therapeutics and Chief Executive Officer at Oblenio Bio.
What check size does Samantha Truex write?
Samantha Truex typically writes checks of $10M – $50M.
Where did Samantha Truex go to school?
Samantha Truex studied at The Tuck School of Business at Dartmouth (MBA); Thayer School of Engineering at Dartmouth (Bachelor of Engineering (B.E.), Biomedical Engineering); Dartmouth College (Bachelor of Arts (B.A.), Biology).

Founder mafias

Same school

Shared employers